EFFICACY AND CLINICAL OUTCOME OF PHILADELPHIA (PH) POSITIVE ACUTE LYMPHOBLASTIC LEUKEMIA (ALL) PATIENTS TREATED WITH SECOND GENERATION TYROSINE KINASE INHIBITORS (TKIS): THE BOLOGNA EXPERIENCE

被引：0
|
作者：
Papayannidis, C. [1 ]
Iacobucci, I. [1 ]
Soverini, S. [1 ]
Paolini, S. [1 ]
Clissa, C. [1 ]
Parisi, S. [1 ]
Abbenante, M. C. [1 ]
Colarossi, S. [1 ]
Gnani, A. [1 ]
Lonetti, A. [1 ]
Ferrari, A. [1 ]
Testoni, N. [1 ]
Amabile, M. [1 ]
Ottaviani, E. [1 ]
Curti, A. [1 ]
Guadagnuolo, V. [1 ]
Baccarani, M. [1 ]
Martinelli, G. [1 ]
机构：
[1] Inst Hematol, Bologna, Italy
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2010年 / 95卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0611
引用
收藏
页码：257 / 257
页数：1
相关论文
共 50 条
  • [1] Efficacy and clinical outcome of Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with second generation tyrosine kinase inhibitors (TKIs): The Bologna experience
    Papayannidis, Cristina
    Lacobucci, Ilaria
    Soverini, Simona
    Colarossi, Sabrina
    Gnani, Alessandra
    Lonetti, Annalisa
    Ferrari, Anna
    Testoni, Nicoletta
    Amabile, Marilina
    Ottaviani, Emanuela
    Abbenante, Maria Chiara
    Curti, Antonio
    Paolini, Stefania
    Lama, Barbara
    Clissa, Cristina
    Parisi, Sarah
    Guadagnuolo, Viviana
    Baccarani, Michele
    Martinelli, Giovanni
    CANCER RESEARCH, 2010, 70
  • [2] Efficacy and Clinical Outcome of Philadelphia (Ph) Positive Acute Lymphoblastic Leukemia (ALL) Patients Treated with Second Generation Tyrosine Kinase Inhibitors (TKIs): The Bologna Experience.
    Papayannidis, Cristina
    Iacobucci, Ilaria
    Soverini, Simona
    Colarossi, Sabrina
    Gnani, Alessandra
    Lonetti, Annalisa
    Baldazzi, Carmen
    Testoni, Nicoletta
    Amabile, Marilina
    Ottaviani, Emanuela
    Abbenante, Maria Chiara
    Curti, Antonio
    Paolini, Stefania
    Lama, Barbara
    Castagnetti, Fausto
    Poerio, Angela
    Clissa, Cristina
    Parisi, Sarah
    Polverelli, Nicola
    Guadagnuolo, Viviana
    Piccaluga, Pier Paolo
    Rosti, Gianantonio
    Baccarani, Michele
    Martinelli, Giovanni
    BLOOD, 2009, 114 (22) : 800 - 800
  • [3] Discontinuation of Tyrosine Kinase Inhibitors (TKIs) in Philadelphia Chromosome-Positive (Ph plus ) Acute Lymphoblastic Leukemia (ALL)
    Samra, Bachar
    Kantarjian, Hagop M.
    Sasaki, Koji
    Konopleva, Marina Y.
    Khouri, Rita
    O'Brien, Susan M.
    Ferrajoli, Alessandra
    Nunez, Cesar
    Kadia, Tapan M.
    Jabbour, Elias
    BLOOD, 2019, 134
  • [4] THE FIRST AND SECOND GENERATION TYROSINE KINASE INHIBITORS ROLE IN THE PHILADELPHIA POSITIVE CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
    Koc, Basak
    Zulfikar, Bulent
    PEDIATRIC BLOOD & CANCER, 2015, 62 : 84 - 84
  • [5] The clinical outcome of adult Philadelphia (Ph)-positive acute lymphoblastic leukemia (ALL).
    Faderl, S
    Kantajian, HM
    Thomas, D
    Cortes, J
    Giles, F
    Estrov, Z
    BLOOD, 1998, 92 (10) : 225A - 225A
  • [6] Results of Treatment with Tyrosine Kinase Inhibitors(TKIs) in Combination with Intensive Chemotherapy in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia(Ph plus ALL)
    Kyo, Taiichi
    Okatani, Takeshi
    Kyo, Kouhei
    Imanaka, Ryouta
    Itagaki, Mitsuhiro
    Katayama, Yuuta
    Iwato, Koji
    Asaoku, Hideki
    BLOOD, 2011, 118 (21) : 652 - 652
  • [7] Upfront treatment with the first and second-generation tyrosine kinase inhibitors in Ph-positive acute lymphoblastic leukemia
    Yu, Guopan
    Chen, Fang
    Yin, Changxin
    Liu, Qifa
    Sun, Jing
    Xuan, Li
    Fan, Zhiping
    Wang, Qiang
    Liu, Xiaoli
    Jiang, Qianli
    Xu, Dan
    ONCOTARGET, 2017, 8 (63): : 107022 - 107032
  • [8] The Bcr-Abl kinase promotes aberrant expression of spliced oncogenic Ikaros isoforms in Philadelphia (Ph) positive acute lymphoblastic leukemia (ALL) patients treated with tyrosine kinase inhibitors
    Iacobucci, Ilaria
    Lonetti, Annalisa
    Ottaviani, Emanuela
    Cilloni, Daniela
    Messa, Francesca
    Paolini, Stefania
    Papayannidis, Cristina
    Piccaluga, Pier Paolo
    Giannoulia, Panagiota
    Soverini, Simona
    Amabile, Marilina
    Saglio, Giuseppe
    Pane, Fabrizio
    Berton, Giorgio
    Baruzzi, Anna
    Vitale, Antonella
    Foa, Robin
    Baccarani, Michele
    Martinelli, Giovanni
    CANCER RESEARCH, 2008, 68 (09)
  • [9] Philadelphia Positive Acute Lymphoblastic Leukemia (Ph plus ALL), Tawam Experience
    Alam, Arif
    al Qawasmeh, Khaled
    Kanbar, Jihad
    Syed, Masood H.
    Lal, Amar
    Hussain, Sabir
    Osman, Hani Y.
    Kristensen, Jorgen
    BLOOD, 2015, 126 (23)
  • [10] Second-Generation Tyrosine Kinase Inhibitors in the Post-Transplant Period in Patients with Chronic Myeloid Leukemia or Philadelphia-Positive Acute Lymphoblastic Leukemia
    Klyuchnikov, Evgeny
    Schafhausen, Philippe
    Kroeger, Nicolaus
    Brummendorf, Tim H.
    Osanmaz, Okay
    Asenova, Svetlana
    Zabelina, Tatjana
    Ocheni, Sunday
    Ayuk, Francis
    Zander, Axel R.
    Bacher, Ulrike
    ACTA HAEMATOLOGICA, 2009, 122 (01) : 6 - 10
12345